/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | PACBPACIFIC BIOSCIENCES |
|---|---|
| Last close | $2.36close 2026-11-09 |
| Change % | +4.66%close 2026-11-09 |
| Market cap | $739Mclose 2026-11-09 |
| P/E | loss, no P/E |
| Revenue | $160M⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldRevenueFromContractWithCustomerIncludingAssessedTax |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Each cell names its period. A ratio row reads not comparable when the companies’ periods differ by more than six weeks or mix a fiscal year with a trailing twelve months, and a figure more than a year older than the company’s newest period is marked older period. No row ranks the companies. Educational only, not investment advice.
| Rev growth (YoY) | 3.9%FY to 2025-12-31 |
| Net income | $-546400000⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldNetIncomeLoss As ofFY ending 2025-12-31 FilingDEF 14A · 0001299130-26-000064 · filed 2026-04-23 Open the filing on EDGAR →Open the XBRL payload →CitePACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB), us-gaap:NetIncomeLoss: -546,400,000 USD, fiscal year ended 2025-12-31. Form DEF 14A, accession 0001299130-26-000064, filed 2026-04-23. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001299130/us-gaap/NetIncomeLoss.json |
| Net margin | -341.5%FY to 2025-12-31 |
| EPS (diluted) | $-1.82⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldEarningsPerShareDiluted As ofFY ending 2025-12-31 Filing10-K · 0001299130-26-000034 · filed 2026-02-25 Open the filing on EDGAR →Open the XBRL payload →CitePACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB), us-gaap:EarningsPerShareDiluted: -1.82 USD per share, fiscal year ended 2025-12-31. Form 10-K, accession 0001299130-26-000034, filed 2026-02-25. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001299130/us-gaap/EarningsPerShareDiluted.json |
| Piotroski F-ScoreUNVALIDATED | 3FY to 2018-12-31, older period |
| Altman Z-ScoreUNVALIDATED | -0.95FY to 2018-12-31, older period |
| Beneish M-ScoreUNVALIDATED | -3.77FY to 2018-12-31, older period |
| Next earnings | 02-06 → 02-16 |